Knowledge

Across topics and issues, borders and industries, we have the thought leadership you need to stay ahead of changes in the law.

Follow us:

Publications

News

COVID-19 Report for Life Sciences and Health Care Companies

The COVID-19 Report is a compilation of coronavirus news, analysis, and insights from around the world to help life sciences and health care companies stay current in this challenging time....

Published Works

Cybersecurity due diligence in health care transactions AHLA's Speaking of health law podcast

In this American Health Law Association (AHLA) podcast episode, Nathan Salminen, Hogan Lovells senior associate, speaks to Jon Moore, Clearwater Chief Risk Officer and Senior Vice President ...

News

Ransomware in Asia-Pacific: how to prepare

Ransomware attacks are on the rise in the Asia-Pacific region, amounting to one of the most significant operational risks faced by businesses in the region. The Asia Insurance Review...

News

Getting The Deal Through: Automotive 2021

For the fifth time, we have collaborated with Lexology to publish Getting the Deal Through: Automotive, our market overview of key issues in the automotive industry covering 19 countries....

News

California AG enlists residents to send CCPA noncompliance letters

On July 19, California’s recently appointed Attorney General, Rob Bonta, launched an interactive tool to aid consumers with drafting notices of noncompliance for businesses who fail...

News

What health systems should know about President Biden’s Executive Order Promoting Competition

On 9 July 2021, President Biden signed an Executive Order on Promoting Competition in the American Economy (“EO”) that takes aim, in part, at the healthcare industry. Although...

News

Time’s really up! FDA authority to crack down on regenerative medicines upheld as grace period ends

On July 9, 2021, the U.S. Food and Drug Administration’s Center for Biologics Evaluation and Research (CBER) added a Q&A page on its website about the May 31 end of the grace...

Insights

New FDA guidance lays out clinical trial sponsor safety reporting requirements
Registered Content

The U.S. Food and Drug Administration (FDA) recently published the new draft guidance “Sponsor Responsibilities — Safety Reporting Requirements and Safety Assessment for...

Published Works

EDPB & EDPS issue joint opinion on the EU’s proposed AI Regulation

On 18 June 2021, the European Data Protection Board (EDPB) and European Data Protection Supervisor (EDPS) issued a joint opinion on the European Union’s proposed AI Regulation, which...

Loading data